Category: Finance
Monsters of Rock: Rio quiet on whether it wants to join BHP’s copper race for Anglo American
Rio Tinto leaves investors guessing on M&A thoughts in mild Brisbane AGM Northern Star adds to resources and reserves in ho-hum exploration update Meteoric [more…]
Lithium Universe estimates North America requires 850,000t of lithium each year to satisfy the nest’s demand
Vertically integrated developer Lithium Universe sent its team to China to see existing lithium refineries up close LU7 is developing the Québec Lithium Processing Hub; [more…]
Long Shortz with Greenvale Energy: Amadeus Basin triple play – helium, hydrogen and hydrocarbons
Stockhead’s Sarah Hughan sits down with Greenvale Energy’s CEO Mark Turner to get the short end of the long story on the company’s latest news. Greenvale has [more…]
ASX Small Caps Lunch Wrap: Who learned there’s honour among thieves this week?
Anyone hoping for a recovery on the ASX this morning after yesterday’s blood-letting was in for a disappointment, as the benchmark managed to bounce even [more…]
Long Shortz with Lithium Energy: $97 million Solaroz sale fuels battery minerals hunt
Stockhead’s Sarah Hughan sits down with Lithium Energy’s executive chairman William Johnson to get the short end of the long story on the company’s latest news. The [more…]
Resources Top 3: Is niobium a ‘niob’rainer or a flash in the pan?
Niobium explorers are soaring thanks to WA1 Resources (ASX:WA1) and its big find in WA’s remote West Arunta region Krakatoa identifies a possible niobium-rare earths [more…]
Broking Bad: Clean up on Aisle 6 as ASX supermarkets unnerve JP Morgan; excite UBS
Welcome to Stockhead’s Broking Bad – Where the analysts go bad, the companies get mad and the shareholders feel sad. There’s certainly been some [more…]
Adavale’s South Australian uranium exploration drive kicks off
Maiden uranium exploration at Adavale’s Mundowdna and Mundowdna South exploration projects in South Australia completed ahead of schedule Program to helping to determine drill targets [more…]
ASX Health Stocks: Immutep shares exciting early results from Phase 2 trial on soft tissue sarcoma
Immutep shares promising early results from Phase 2 trial on soft tissue sarcoma (STS) This trial is the first of its kind, and evaluates IMM’s [more…]
ASX Quarterly Health Wrap: Which companies are making progress in clinical trials?
It’s the quarterly season again as the ASX market announcements page becomes increasingly flooded with update lodgements. To save you the trouble of trudging through [more…]
